कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Madrigal Pharmaceuticals, Inc. (MDGL), जिसमें शामिल हैं 20 खरीद और 27 बिक्री. कुल अंदरूनी खरीद मूल्य $37.6M और कुल अंदरूनी बिक्री मूल्य $8.97M.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Taub Rebecca, Sibold William John, Dier Mardi. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — MDGL
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-03-06 |
Taub Rebecca |
Director |
सूचित बिक्री |
491 |
$431.94 |
$212.08K |
452,213 |
| 2026-03-06 |
Sibold William John |
President and CEO |
सूचित बिक्री |
1,663 |
$431.94 |
$718.32K |
161,829 |
| 2026-03-06 |
Dier Mardi |
EVP and CFO |
सूचित बिक्री |
40 |
$437.65 |
$17.51K |
12,490 |
| 2026-03-06 |
Huntsman Carole |
Chief Commercial Officer |
सूचित बिक्री |
419 |
$431.94 |
$180.98K |
12,692 |
| 2026-03-06 |
Kelley Shannon T |
General Counsel |
सूचित बिक्री |
360 |
$431.94 |
$155.5K |
12,138 |
| 2026-03-04 |
Sibold William John |
President and CEO |
RSU पुरस्कार |
18,743 |
$434.80 |
$8.15M |
18,743 |
| 2026-03-04 |
Dier Mardi |
EVP and CFO |
RSU पुरस्कार |
6,519 |
$434.80 |
$2.83M |
6,519 |
| 2026-03-04 |
Soergel David |
Chief Medical Officer |
RSU पुरस्कार |
5,467 |
$434.80 |
$2.38M |
5,467 |
| 2026-03-04 |
Huntsman Carole |
Chief Commercial Officer |
RSU पुरस्कार |
4,986 |
$434.80 |
$2.17M |
4,986 |
| 2026-03-04 |
Kelley Shannon T |
General Counsel |
RSU पुरस्कार |
5,022 |
$434.80 |
$2.18M |
5,022 |
| 2026-03-02 |
Dier Mardi |
EVP and CFO |
सूचित बिक्री |
1,183 |
$427.21 |
$505.39K |
9,257 |
| 2026-02-23 |
Levy Richard S |
Director |
विकल्प प्रयोग (बिक्री) |
2,500 |
$7.36 |
$18.4K |
- |
| 2026-01-26 |
Taub Rebecca |
Director |
सूचित बिक्री |
647 |
$492.42 |
$318.6K |
452,704 |
| 2026-01-26 |
Levy Richard S |
Director |
विकल्प प्रयोग (बिक्री) |
4,000 |
$16.46 |
$65.84K |
- |
| 2026-01-26 |
Sibold William John |
President and CEO |
सूचित बिक्री |
1,577 |
$492.42 |
$776.55K |
148,497 |
| 2026-01-26 |
Huntsman Carole |
Chief Commercial Officer |
सूचित बिक्री |
570 |
$494.59 |
$281.92K |
9,122 |
| 2026-01-20 |
Taub Rebecca |
Director |
सूचित बिक्री |
2,238 |
$490.77 |
$1.1M |
453,351 |
| 2026-01-20 |
Kelley Shannon T |
General Counsel |
सूचित बिक्री |
429 |
$501.40 |
$215.1K |
8,481 |
| 2026-01-15 |
Thakkar Rita |
Chief Accounting Officer |
RSU पुरस्कार |
1,826 |
$495.88 |
$905.48K |
1,826 |
| 2026-01-12 |
Thakkar Rita |
Officer |
अज्ञात |
- |
- |
- |
- |
| 2026-01-09 |
Friedman Paul A |
Director |
विकल्प प्रयोग (बिक्री) |
24,520 |
$15.80 |
$387.42K |
280 |
| 2026-01-09 |
Taub Rebecca |
Director |
सूचित बिक्री |
271 |
$534.18 |
$144.76K |
457,242 |
| 2025-06-20 |
Bate Kenneth |
Director |
RSU पुरस्कार |
1,290 |
$285.73 |
$368.59K |
1,290 |
| 2025-06-20 |
Friedman Paul A |
Director |
RSU पुरस्कार |
1,290 |
$285.73 |
$368.59K |
1,290 |
| 2025-06-20 |
Baker Bros. Advisors Lp |
Director |
RSU पुरस्कार |
2,580 |
$285.73 |
$737.18K |
2,580 |
| 2025-06-20 |
Fouse Jacqualyn A |
Director |
RSU पुरस्कार |
366 |
$285.73 |
$104.58K |
366 |
| 2025-06-20 |
Levy Richard S |
Director |
RSU पुरस्कार |
1,290 |
$285.73 |
$368.59K |
1,290 |
| 2025-06-20 |
Daly James M |
Director |
RSU पुरस्कार |
1,290 |
$285.73 |
$368.59K |
1,290 |
| 2025-05-15 |
Soergel David |
Chief Medical Officer |
RSU पुरस्कार |
7,545 |
- |
- |
7,545 |
| 2025-04-21 |
Soergel David |
Officer |
अज्ञात |
- |
- |
- |
- |
| 2025-03-13 |
Craves Fred B |
Director |
विकल्प प्रयोग (बिक्री) |
7,742 |
$65.06 |
$503.69K |
- |
| 2025-03-12 |
Craves Fred B |
Director |
विकल्प प्रयोग (बिक्री) |
6,000 |
$111.06 |
$666.36K |
- |
| 2025-03-10 |
Fouse Jacqualyn A |
Director |
अज्ञात |
- |
- |
- |
- |
| 2025-03-10 |
Fouse Jacqualyn A |
Director |
RSU पुरस्कार |
894 |
- |
- |
894 |
| 2025-03-10 |
Dier Mardi |
SVP and CFO |
सूचित बिक्री |
258 |
$323.04 |
$83.34K |
10,440 |
| 2025-03-05 |
Taub Rebecca |
Pres., R&d, and CMO |
RSU पुरस्कार |
7,381 |
$347.28 |
$2.56M |
7,381 |
| 2025-03-05 |
Sibold William John |
President and CEO |
RSU पुरस्कार |
22,009 |
$347.28 |
$7.64M |
22,009 |
| 2025-03-05 |
Dier Mardi |
SVP and CFO |
RSU पुरस्कार |
6,374 |
$347.28 |
$2.21M |
6,374 |
| 2025-03-05 |
Waltermire Robert E. |
Senior VP, Chief Pharma Dev. |
RSU पुरस्कार |
1,157 |
$347.28 |
$401.8K |
1,157 |
| 2025-03-05 |
Huntsman Carole |
Chief Commercial Officer |
RSU पुरस्कार |
5,703 |
$347.28 |
$1.98M |
5,703 |
| 2025-03-05 |
Kelley Shannon T |
General Counsel |
RSU पुरस्कार |
5,368 |
$347.28 |
$1.86M |
5,368 |
| 2025-03-03 |
Dier Mardi |
SVP and CFO |
सूचित बिक्री |
774 |
$323.54 |
$250.42K |
6,914 |
| 2025-03-03 |
Huntsman Carole |
Chief Commercial Officer |
सूचित बिक्री |
563 |
$335.00 |
$188.61K |
8,604 |
| 2025-03-03 |
Kelley Shannon T |
General Counsel |
सूचित बिक्री |
415 |
$335.00 |
$139.03K |
7,290 |
| 2025-02-28 |
Waltermire Robert E. |
Senior VP, Chief Pharma Dev. |
सूचित बिक्री |
175 |
$341.55 |
$59.77K |
3,728 |
| 2025-02-27 |
Bate Kenneth |
Director |
विकल्प प्रयोग (बिक्री) |
9,470 |
$65.06 |
$616.12K |
- |
| 2025-02-27 |
Sibold William John |
President and CEO |
विकल्प प्रयोग (बिक्री) |
50,000 |
- |
- |
- |
| 2025-02-27 |
Daly James M |
Director |
विकल्प प्रयोग (बिक्री) |
9,470 |
$65.06 |
$616.12K |
- |
| 2025-01-24 |
Taub Rebecca |
Pres., R&d, and CMO |
सूचित बिक्री |
648 |
$335.24 |
$217.24K |
456,662 |
| 2025-01-24 |
Sibold William John |
President and CEO |
सूचित बिक्री |
1,584 |
$335.24 |
$531.02K |
54,303 |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति
